Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:MHUA NASDAQ:NXL OTCMKTS:VYCO NASDAQ:XAIR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMHUAMeihua International Medical Technologies$0.44-3.1%$0.43$0.25▼$1.47$13.91M0.79221,342 shs11,446 shsNXLNexalin Technology$1.19+8.7%$1.13$0.59▼$4.49$20.36M3.7185,395 shs210,511 shsVYCOVycor Medical$0.10-22.5%$0.12$0.04▼$0.50$3.34M-0.4216,634 shs18,499 shsXAIRBeyond Air$3.23-0.9%$3.73$2.90▼$13.52$13.96M0.2282,660 shs226,367 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMHUAMeihua International Medical Technologies0.00%-4.88%+13.90%+56.76%-53.14%NXLNexalin Technology0.00%+9.54%+4.81%-37.14%-12.10%VYCOVycor Medical0.00%-22.48%-13.04%+47.06%+13.64%XAIRBeyond Air0.00%-5.56%-29.68%-29.50%-71.29%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMHUAMeihua International Medical Technologies0.7422 of 5 stars0.03.00.00.01.51.70.6NXLNexalin Technology2.2593 of 5 stars3.55.00.00.00.01.70.0VYCOVycor MedicalN/AN/AN/AN/AN/AN/AN/AN/AXAIRBeyond Air4.6024 of 5 stars3.75.00.03.53.00.81.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMHUAMeihua International Medical Technologies 0.00N/AN/AN/ANXLNexalin Technology 3.00Buy$5.00321.94% UpsideVYCOVycor Medical 0.00N/AN/AN/AXAIRBeyond Air 3.40Buy$23.67632.71% UpsideCurrent Analyst Ratings BreakdownLatest VYCO, NXL, XAIR, and MHUA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/17/2025XAIRBeyond AirD Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy7/17/2025XAIRBeyond AirD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$11.00(Data available from 7/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMHUAMeihua International Medical Technologies$96.90M0.14$0.44 per share0.99$6.34 per share0.07NXLNexalin Technology$170K119.75N/AN/A$0.28 per share4.23VYCOVycor Medical$1.59M2.10N/AN/A($0.11) per share-0.91XAIRBeyond Air$3.70M3.77N/AN/A$3.32 per share0.97Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMHUAMeihua International Medical Technologies$10.84MN/A0.00∞N/AN/AN/AN/AN/ANXLNexalin Technology-$7.61M-$0.83N/A∞N/A-6,529.77%-277.92%-245.37%8/14/2025 (Estimated)VYCOVycor Medical-$110KN/A0.00∞N/A-6.86%N/A-11.44%8/11/2025 (Estimated)XAIRBeyond Air-$46.62M-$15.80N/AN/AN/A-1,258.46%-233.96%-113.92%8/5/2025 (Estimated)Latest VYCO, NXL, XAIR, and MHUA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q1 2026XAIRBeyond Air-$0.08N/AN/AN/A$1.75 millionN/A6/17/2025Q4 2025XAIRBeyond Air-$2.80-$1.80+$1.00-$0.09$1.39 million$1.15 million5/15/2025Q1 2025VYCOVycor MedicalN/A-$0.01N/A-$0.01N/A$0.44 million5/13/2025Q1 2025NXLNexalin Technology-$0.10-$0.15-$0.05-$0.15$0.04 million$0.04 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMHUAMeihua International Medical TechnologiesN/AN/AN/AN/AN/ANXLNexalin TechnologyN/AN/AN/AN/AN/AVYCOVycor MedicalN/AN/AN/AN/AN/AXAIRBeyond AirN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMHUAMeihua International Medical TechnologiesN/A5.265.21NXLNexalin TechnologyN/A4.564.25VYCOVycor MedicalN/A0.130.09XAIRBeyond Air0.643.202.72Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMHUAMeihua International Medical Technologies1.17%NXLNexalin Technology0.65%VYCOVycor MedicalN/AXAIRBeyond Air31.50%Insider OwnershipCompanyInsider OwnershipMHUAMeihua International Medical Technologies66.56%NXLNexalin Technology25.26%VYCOVycor MedicalN/AXAIRBeyond Air19.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMHUAMeihua International Medical Technologies62031.90 million10.67 millionNot OptionableNXLNexalin Technology317.18 million12.84 millionNot OptionableVYCOVycor Medical633.42 millionN/ANot OptionableXAIRBeyond Air704.32 million3.48 millionOptionableVYCO, NXL, XAIR, and MHUA HeadlinesRecent News About These CompaniesWall Street Zen Upgrades Beyond Air (NASDAQ:XAIR) to SellJuly 20 at 2:49 AM | americanbankingnews.comBeyond Air (NASDAQ:XAIR) Research Coverage Started at D. Boral CapitalJuly 20 at 2:03 AM | americanbankingnews.comXAIR | Beyond Air Inc. Annual Cash Flow Statement | MarketWatchJuly 19 at 12:22 AM | marketwatch.comD. Boral Capital Initiates Coverage of Beyond Air (XAIR) with Buy RecommendationJuly 18 at 9:16 AM | msn.comBeyond Air, Inc. (XAIR) - Yahoo FinanceJuly 12, 2025 | finance.yahoo.comBeyond Air (NASDAQ:XAIR) Stock Price Down 7.1% - What's Next?July 11, 2025 | americanbankingnews.comBeyond Air Implements Reverse Stock Split for Nasdaq ComplianceJuly 10, 2025 | tipranks.comBeyond Air Inc.June 26, 2025 | barrons.comHere's Why Beyond Air (XAIR) Could be Great Choice for a Bottom FisherJune 26, 2025 | zacks.comBeyond Air (XAIR) Q4 2025 Earnings Call TranscriptJune 21, 2025 | msn.comBeyond Air, Inc. (NASDAQ:XAIR) Q4 2025 Earnings Call TranscriptJune 20, 2025 | msn.comBeyond Air posts narrower-than-feared Q4 loss, shares surge 15%June 18, 2025 | investing.comBeyond Air Reports Strong Revenue Growth and Strategic AdvancesJune 17, 2025 | tipranks.comBeyond Air, Inc. (XAIR) Q4 2025 Earnings Call TranscriptJune 17, 2025 | seekingalpha.comBeyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate UpdateJune 17, 2025 | finance.yahoo.comBeyond Air, Inc. (XAIR) Reports Q4 Loss, Misses Revenue EstimatesJune 17, 2025 | zacks.comBeyond Air Stock Dips After Mixed Q4 Results: Here's What To KnowJune 17, 2025 | benzinga.comBeyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate UpdateJune 17, 2025 | globenewswire.comBeyond Air Submits PMA Supplement Application for Next-Generation LungFit PH II Nitric Oxide GeneratorJune 16, 2025 | quiverquant.comQBeyond Air Submits FDA PMA Supplement for Next Generation LungFit® PHJune 16, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVYCO, NXL, XAIR, and MHUA Company DescriptionsMeihua International Medical Technologies NASDAQ:MHUA$0.44 -0.01 (-3.09%) As of 11:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Meihua International Medical Technologies Co., Ltd. engages in the manufacture, sells, and marketing of medical consumables in the People's Republic of China. The company offers class I, II, and III disposable medical devices. Its products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles, as well as electronic pumps. The company also distributes disposable medical devices sourced from other manufacturers to customers in China. In addition, it offers COVID-19 products comprising disposable medical masks. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.Nexalin Technology NASDAQ:NXL$1.18 +0.10 (+8.72%) As of 11:54 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.Vycor Medical OTCMKTS:VYCO$0.10 -0.03 (-22.48%) As of 11:14 AM EasternVycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement which grants for the license to provide NovaVision's products and therapies to patients and professionals in Germany, Austria and Switzerland. It primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.Beyond Air NASDAQ:XAIR$3.23 -0.03 (-0.92%) As of 11:55 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/14 - 07/18 Q2 Could Be the Catalyst PayPal Investors Have Been Waiting For Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
